MX2015005898A - Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo. - Google Patents

Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo.

Info

Publication number
MX2015005898A
MX2015005898A MX2015005898A MX2015005898A MX2015005898A MX 2015005898 A MX2015005898 A MX 2015005898A MX 2015005898 A MX2015005898 A MX 2015005898A MX 2015005898 A MX2015005898 A MX 2015005898A MX 2015005898 A MX2015005898 A MX 2015005898A
Authority
MX
Mexico
Prior art keywords
insulin resistance
weight gain
lactobacillus rhamnosus
rhamnosus strain
reducing weight
Prior art date
Application number
MX2015005898A
Other languages
English (en)
Inventor
Liping Zhao
Jian Shen
Jingjing Wang
Martin Saul Obin
Muriel Derrien
Emilie Rocher
Johan Van Hylckama Vlieg
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of MX2015005898A publication Critical patent/MX2015005898A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

El presente invento se refiere a la utilización de la cepa CNCM I-3690 de Lactobacillus rhamnosus en un sujeto, para la reducción de la ganancia de peso inducida por la dieta o de la resistencia a la insulina inducida por la dieta, o de ambas al mismo tiempo y para el tratamiento de los trastornos que derivan de esas dos, tales como el sobrepeso, la obesidad y los trastornos relacionados con la obesidad.
MX2015005898A 2012-11-12 2012-11-12 Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo. MX2015005898A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/084462 WO2014071633A1 (en) 2012-11-12 2012-11-12 Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance

Publications (1)

Publication Number Publication Date
MX2015005898A true MX2015005898A (es) 2016-02-05

Family

ID=50683962

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005898A MX2015005898A (es) 2012-11-12 2012-11-12 Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo.

Country Status (11)

Country Link
US (1) US10022407B2 (es)
EP (1) EP2917335B1 (es)
JP (1) JP2016501010A (es)
CN (1) CN104870632A (es)
AR (1) AR093426A1 (es)
BR (1) BR112015010698A2 (es)
CA (1) CA2891618A1 (es)
ES (1) ES2675309T3 (es)
MX (1) MX2015005898A (es)
RU (1) RU2015122748A (es)
WO (1) WO2014071633A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110023487B (zh) * 2016-09-30 2023-04-18 Cj第一制糖株式会社 新型清酒乳杆菌和包含其的组合物
US20200155622A1 (en) * 2017-05-22 2020-05-21 Compagnie Gervais Danone Compositions and methods for decreasing a population of bilophila wadsworthia or inhibiting the growth thereof
KR101864347B1 (ko) * 2017-09-06 2018-06-05 주식회사 지놈앤컴퍼니 락토바실러스 람노수스 lm1019 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물
CN112672749A (zh) * 2018-04-11 2021-04-16 韩国生命工学研究院 具有肥胖预防或治疗效果的新的长双歧杆菌菌株或鼠李糖乳杆菌菌株及其用途
CN111164201B (zh) * 2018-07-02 2023-09-12 葡萄王生技股份有限公司 用于改善代谢症候群的副干酪乳杆菌gks6、其用途、医药组合物及可食用组合物
CN109757730B (zh) * 2019-01-31 2021-06-04 山东环亿生物科技有限公司 一种具有降血脂、血压以及血糖的组合物及其制备方法
CN113018319A (zh) * 2021-01-21 2021-06-25 中南大学 一种用于缓解因长期低剂量辐射暴露所致胰岛素抵抗的复合菌剂及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4280016B2 (ja) * 2002-02-28 2009-06-17 雪印乳業株式会社 糖尿病合併症予防・改善・治療剤
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
JP5144263B2 (ja) 2005-07-26 2013-02-13 ネステク ソシエテ アノニム 抗肥満剤および抗肥満食品
BRPI0707336A2 (pt) * 2006-01-27 2011-05-03 Danisco uso de microorganismos probióticos para o tratamento e prevenção de obesidade e distúrbios relacionados
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2022502A1 (en) 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö
EA024911B1 (ru) * 2010-01-08 2016-11-30 Компани Жервэ Данон Лактобациллы с антиоксидантным действием

Also Published As

Publication number Publication date
AR093426A1 (es) 2015-06-10
EP2917335A4 (en) 2016-06-29
BR112015010698A2 (pt) 2017-07-11
JP2016501010A (ja) 2016-01-18
CA2891618A1 (en) 2014-05-15
US10022407B2 (en) 2018-07-17
ES2675309T3 (es) 2018-07-10
RU2015122748A (ru) 2017-01-10
EP2917335A1 (en) 2015-09-16
US20150297646A1 (en) 2015-10-22
EP2917335B1 (en) 2018-04-04
CN104870632A (zh) 2015-08-26
WO2014071633A1 (en) 2014-05-15

Similar Documents

Publication Publication Date Title
MX2015005898A (es) Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo.
MX2015007971A (es) Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina.
HK1226100B (zh) 雙歧桿菌乳酸亞種(bifidobacterium animalis subsp．lactis)cect 8145的新菌株及其用於治療和/或預防超重和肥胖症以及相關疾病的用途
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
SG10202112104UA (en) Lactobacillus paracasei strain and use thereof
IN2012DN02463A (es)
EP2650002A4 (en) BIFIDOBACTERIUM CECT 7765 AND ITS USE IN PREVENTING AND / OR TREATING OVERWEIGHT, OBESITY AND ASSOCIATED PATHOLOGIES
MX2011008400A (es) Lactobacillus rhamnosus cncm i-4096 y el control del peso.
NZ712959A (en) Probiotic strains for use in treatment or prevention of osteoporosis
EP2898061A4 (en) PROBIOTIC COMPOSITIONS AND METHOD FOR THE TREATMENT OF ADIPOSITAS AND DISEASES RELATED TO ADIPOSITAS
MX2011008399A (es) Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso.
EA201491848A1 (ru) Биозащита с использованием штаммов lactobacillus paracasei
EP2678420A4 (en) AUTOTROPHEN HYDROGEN PRODUCING BACTERIA AND USES THEREOF
MX344303B (es) Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
PT2747578T (pt) O método para obter uma estirpe de bacteriófago, estirpes específicas de bacteriófago e sua utilização
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
PL2707476T3 (pl) Szczep lactobacillus fermentum cect 7472 o właściwościach probiotycznych
ZA201208978B (en) Probiotic strains for use in improving transepithelial resistance
MX2015002934A (es) Metodos de administracion de rifaximina para perdida de peso y tratamiento de obesidad.
MX350212B (es) Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales.
MX345948B (es) Uso de cepas mutantes resistentes a la nisina de lactobacilos para reducir la post-acidificación en los productos alimenticios.
HK1208159A1 (en) Sorcs1 for use in the treatment of obesity and overweight sorcs1
WO2012107601A8 (es) Uso de una cepa de lactobacillus bulgaricus para el tratamiento de la inmunosenescencia
UA96709C2 (ru) Штамм реликтовых бактерий bacillus sp. f, который имеет иммуномодулирующую активность и геропротекторной способность